Erschienen in:
01.06.2015 | Psychiatry and Preclinical Psychiatric Studies - Short communication
BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy
verfasst von:
Alexandra Kleimann, Alexandra Kotsiari, Wolfgang Sperling, Michael Gröschl, Annemarie Heberlein, Kai G. Kahl, Thomas Hillemacher, Stefan Bleich, Johannes Kornhuber, Helge Frieling
Erschienen in:
Journal of Neural Transmission
|
Ausgabe 6/2015
Einloggen, um Zugang zu erhalten
Abstract
We examined potential changes in brain-derived neurotrophic factor (BDNF) serum levels and promoter methylation of the BDNF gene in 11 patients with treatment-resistant major depressive disorder during a series of electroconvulsive therapy (ECT). Blood samples were taken before, 1 and 24 h after ECT treatment sessions 1, 4, 7 and 10. Patients remitting under ECT had significantly lower mean promoter methylation rates, especially concerning the exon I promoter, compared to non-remitters (both p < 0.002). These findings may point to a depression subtype in which ECT is particularly beneficial.